Acetylon Pharmaceuticals' Corporate Minority Round

Acetylon Pharmaceuticals raised a round of funding on February 09, 2012. Investors include Celgene.

Acetylon Pharmaceuticals is a provider in the development of small molecule drugs targeting epigenetic mechanisms for the enhancement of therapeutic outcomes in cancer and other critical human disease…

Articles about Acetylon Pharmaceuticals' Corporate Minority Round: